S&CO Inc. Buys 4,762 Shares of Humana Inc. (NYSE:HUM)

S&CO Inc. lifted its holdings in Humana Inc. (NYSE:HUM) by 16.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,760 shares of the insurance provider’s stock after acquiring an additional 4,762 shares during the period. S&CO Inc.’s holdings in Humana were worth $10,693,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in HUM. Creative Financial Designs Inc. ADV boosted its stake in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its holdings in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares during the period. Atwood & Palmer Inc. bought a new position in shares of Humana in the third quarter worth $29,000. Ashton Thomas Securities LLC bought a new stake in Humana during the third quarter valued at $31,000. Finally, Your Advocates Ltd. LLP boosted its stake in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the period. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HUM. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft cut their price objective on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Stephens reaffirmed an “equal weight” rating and set a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Oppenheimer dropped their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Finally, Leerink Partners lowered shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Stock Down 2.6 %

Shares of NYSE:HUM opened at $275.67 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm’s 50-day simple moving average is $281.36 and its 200-day simple moving average is $331.81. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The company has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities research analysts predict that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.